Exact Sciences
EXAS
#1765
Rank
S$12.65 B
Marketcap
$68.39
Share price
-3.29%
Change (1 day)
-15.91%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -S$0.21 Billion

According to Exact Sciences's latest financial reports the company's current earnings are S$2.61 Billion. In 2023 the company made an earning of -S$0.25 Billion, an increase over its 2022 earnings that were of -S$0.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.21 Billion-15.7%
2023 -S$0.25 Billion-69.98%
2022 -S$0.83 Billion-25.55%
2021 -S$1.11 Billion1.68%
2020 -S$1.09 Billion271.17%
2019 -S$0.3 Billion58.99%
2018 -S$0.19 Billion20.89%
2017 -S$0.16 Billion-30.95%
2016 -S$0.23 Billion5.09%
2015 -S$0.21 Billion57.24%
2014 -S$0.14 Billion116.53%
2013 -S$61.51 Million
2011 -S$38.3 Million143.73%
2010 -S$15.72 Million27.85%
2009 -S$12.29 Million0.27%
2008 -S$12.26 Million-20.95%
2007 -S$15.51 Million-13.53%
2006 -S$17.93 Million-10.07%
2005 -S$19.94 Million-21.81%
2004 -S$25.51 Million-33.44%
2003 -S$38.32 Million-6.51%
2002 -S$40.98 Million17.95%
2001 -S$34.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.21 Billion-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
S$87.52 M-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$72.79 Million-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$46.46 Million-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.84 B-4,883.42%๐Ÿ‡ซ๐Ÿ‡ท France